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A B S T R A C T
The development of high-throughput technologies in the last decade produced an exponential increase in the
amount of biological data available. The case of redox biology and apoptosis is not an exception, and nowadays
there is a need to integrate information from multiple “omics” studies. Therefore, validation of proposed dis-
coveries is essential. However, the study in biological systems of the effect of the massive amounts of sequence
variation data generated with next-generation sequencing (NGS) technologies can be a very difficult and ex-
pensive process. In this context, the present study aimed to demonstrate the advantages of a computational
methodology to systematically analyze the structural and functional effects of protein variants, in order to
prioritize further studies. This approach stands out for its easy implementation, low costs and low time con-
sumed. First, the possible impact of mutations on protein structure and function was tested by a combination of
tools based on evolutionary and structural information. Next, homology modeling was performed to predict and
compare the 3D protein structures of unresolved amino acid sequences obtained from genomic resequencing.
This analysis applied to the bovine GSTP1 allowed to determine that some of amino acid substitutions may
generate important changes in protein structure and function. Moreover, the haplotype analysis highlighted
three structure variants worthwhile studying through in vitro or in vivo experiments.
1. Introduction
The development of high-throughput technologies in the last decade
produced an exponential increase in the amount of biological data
available. The growth of the “omics” fields allowed the detection of
variations in molecular components at different levels [1]; thereby,
from one sample it might be obtained information from its genome
structure and variants, genes and proteins expression patterns, and
metabolites concentration and fluxes, among others [2]. The case of
redox biology and apoptosis is not an exception, and nowadays there is
a need to integrate information from proteomic, genomic, tran-
scriptomic and metabolomic studies [3–5]. Considering this vast spec-
trum and amount of information, the increase of false positive signals
has been proved and discussed [6,7], hence validation of proposed
discoveries is essential [8]. For this task, identifying worthwhile
studying cases, separating true signals from false ones, is challenging,
and, in this sense, in silico studies could help identifying and prioritizing
results to be further in vitro or in vivo validated.
In particular, the next-generation sequencing (NGS) technologies
generate massive amounts of information on sequence variability.
However, the study of the effect of such great volume of sequence
variation data in a biological system can be a very difficult and ex-
pensive process. On the contrary, in silico analysis methods are easy to
perform, cost-effective, reliable and less time-consuming [9], offering a
feasible solution to assess the potential impact of amino acid changes.
Since these techniques are based on protein structure and sequence,
they can predict phenotypic changes arising from genomic variation.
Particularly, non-synonymous SNPs (nsSNPs) modify the sequence of
proteins and could possibly affect their activity. Therefore, our ability
to select nsSNPs for experimental studies can be enhanced by
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performing preliminary in silico studies, analyzing the potential impact
of an amino acid variant on protein structure and function [10].
Within cell redox state, Glutathione S-Transferasa P1 (GSTP1) is a
key enzyme. This enzyme is part of the Glutathione S-transferases
(GSTs, E.C. 2.5.1.18) superfamily found in organisms from all kingdoms
of life, with important biological roles and multiple biomedical and
biotechnological applications [11]. One of GSTs major roles is cell
protection against xenobiotic substances and products of oxidative
stress, conjugating electrophilic and hydrophobic substrates and re-
active oxygen species with glutathione (GSH). In addition, GSTs show
non-catalytic functions modulating signaling processes that regulate
cell proliferation, differentiation and apoptosis [12,13]. Previous stu-
dies have shown that GSTP1 haplotypes have differential effects on
cellular proliferation and apoptosis [14]. While many studies have fo-
cused on correlating the post mortem activity of antioxidant enzymes
with oxidation processes, the information on the role of GSTP1 on
muscle oxidative deterioration and apoptosis is relatively scarce
[15,16]. When the animal dies, muscle cells remain alive for a period of
time until oxygen and nutrients depletion, herein, the first steps of the
post mortem conversion of muscle into meat could be used as a model of
cellular extreme oxidative stress. In this sense, apoptosis is believed to
be the beginning of a complex process that includes a number of phy-
siological and physicochemical changes which occur during and shortly
after harvesting [17].
In this research we present a computational methodology to analyze
the effects of variants on protein structure and function, to select the
haplotype variants to be further studied by in vitro biochemical assays.
The utility of this method is presented for the case of bovine GSTP1
structural variants in the context of the redox stability and apoptosis
related to the conversion of muscle into meat, based on the hypothe-
sized that an alteration in GSTP1 protein activity due to structural
variants would lead to differential post mortem apoptosis development
and hence differential muscle oxidative stability.
2. Materials and methods
2.1. DNA samples, resequencing and haplotype reconstruction
Purified DNA samples were selected from the Veterinary Genetics
Institute DNA Sample Bank (IGEVET, UNLP-CONICET; http://www.
igevet.gob.ar). DNA was extracted from hair using the NaOH/HCl
protocol [18] or blood using the Wizard® Genomic DNA Purification Kit
(Promega, USA), following the manufacturer's instructions. The re-
sequencing set comprised 13 bovine DNA samples from several breeds
(Angus, Brahman, Creole, Hereford, Holstein, Nellore and Wagyu) to
make best use of genetic diversity. The coding regions of the GSTP1
gene were amplified using the primers and PCR protocols detailed in
Supplementary Table 1; they were then sequenced using the sequencing
facilities available at IGEVET (http://www.igevet.gob.ar/servicios.
html). The obtained sequences were aligned and analyzed to identify
the polymorphic positions using DNAMAN v4.15 (Lynnon Corp., Ca-
nada). Finally, haplotypes were reconstructed with PHASE v2.1.1 ran
with standard parameters [19] and predicted mRNA (p-mRNA) and
protein (p-Prot) were obtained for each GSTP1 haplotype.
2.2. Functional analysis of GSTP1 amino acid substitutions
For the functional analysis, several open source tools for sequence-
and structure-based approaches were employed to analyze and compare
the amino acid substitution effect on the structure, function and sta-
bility of the predicted proteins. The reported consensus GSTP1 protein
(NP_803482.1) at the NCBI database (https://www.ncbi.nlm.nih.gov/
protein) was used as control and for comparison with each of the one
amino acid substituted theoretical proteins. The following tools were
used:
SIFT - Sorting Intolerant from Tolerant (http://sift.jcvi.org/www/
SIFT_seq_submit2.html) [20] was used to predict the deleterious score
of the substituted amino acids according to the conservation of each
residue from an evolutionary point of view. Output scores were clas-
sified as damaging (0–0.05), potentially damaging (between 0.05 and
0.10), and neutral (above 0.10).
PROVEAN - Protein Variation Effect Analyzer (http://provean.jcvi.
org/seq_submit.php) was used to predict the possible deleterious effect
of an amino acid substitution on protein structure and function. Protein
variants were considered deleterious if the final output score was below
the threshold score of −2.5, and neutral if it was above such score.
PolyPhen-2 - Polymorphism Phenotyping v2 (http://genetics.bwh.
harvard.edu/pph2/) [21] was used to predict the possible impact of
amino acid substitutions on protein structure and function by using
straightforward physical and evolutionary comparative considerations.
Mutations were classified as probably damaging (≥ 0.85), possibly
damaging (0.15–0.85), and benign (0.00– 0.15).
PANTHER (http://www.pantherdb.org/tools/csnpScoreForm.jsp)
was used to further analyze the effect of mutations on protein function
from an evolutionary point of view. Mutations were classified as
probably damaging, when the preservation time of a residue was
greater than 450 million years; possibly damaging, when it was be-
tween 200 and 450; and probably benign if it was less than 200.
MutPred2 (http://mutpred.mutdb.org/) [22] was used to calculate
the probability that an amino acid substitution was pathogenic (over
0.8) or non-pathogenic (below 0.8).
I-Mutant Suite 3.0 (http://gpcr2.biocomp.unibo.it/cgi/predictors/I-
Mutant3.0/I-Mutant3.0.cgi) [23] was used to predict protein stability
changes due to single-site mutations, according to the change in un-
folding Gibbs free energy (DDG) between the wild type and the mutated
proteins. Mutations were classified as largely destabilizing protein
structure (DDG lower than −0.5 Kcal/mol), largely stabilizing (DDG
higher than 0.5 Kcal/mol), or as having a weak effect (DDG between
−0.5 and 0.5 Kcal/mol). The input used here was the structure of the
reported GSTP1 protein at NCBI, modeled with the I-TASSER server
(Iterative Threading ASSEmbly Refinement; https://zhanglab.ccmb.
med.umich.edu/I-TASSER/) [24].
HOPE - Have (y)Our Protein Explained (http://www.cmbi.ru.nl/
hope/) [25] was used to obtain a prediction and an analysis of the ef-
fect of each mutation found on the 3D structure and function of GSTP1.
This server performs a BLAST search on several databases such as
UniProt and the Protein Data Bank (PDB) to collect structural in-
formation and generate the analysis.
2.3. Molecular modeling and visualization
The tertiary structure of the GSTP1 protein was modeled to compare
the structures of the native and mutant proteins. Since Bos taurus GSTP1
protein tertiary structure is not yet available in the PDB, the I-TASSER
server was used to model the 3D structure of the primary sequence of
GSTP1 obtained from the NCBI database. Then, haplotypes obtained
after the resequencing step were also 3D-modeled with I-TASSER.
Afterwards, Swiss PdbViewer (v4.1.0) (http://www.expasy.org/spdbv/
) [26] was used for model visualization and image generation. In ad-
dition, this software was used to estimate p-Prot volume and surface
and the cavity containing the active site. The deviation between hap-
lotypes and the consensus modeled structures was evaluated by their
Root Mean Square Deviation (RMSD) values.
3. Results
3.1. Sequencing and haplotype reconstruction summary
Sequence alignment allowed to detect a total of 36 polymorphic
positions located in exons (15), 5 ´UTR region (8) and promoter (13)
(Supplementary Figure 1). A total of 24 possible haplotypes were ob-
tained with PHASE, taking into account all the detected SNPs. For
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protein diversity analysis, only SNPs located in the exonic regions were
considered, obtaining a total of 11 different p-mRNA (Supplementary
Table 2). Further, the analysis of the corresponding amino acid se-
quence for those p-mRNAs resulted in seven possible translated primary
structures (p-Prot) for GSTP1 protein, including 11 non-synonymous
amino acid substitutions distributed in the different breeds when
compared to the reported sequence of this protein (Table 1).
3.2. Effect of the predicted non-synonymous amino acid changes on
structure and stability
To determine whether the identified non-synonymous amino acid
substitutions affected GSTP1 function or stability, we further analyzed
these variants using six in silico prediction algorithms: SIFT, PROVEAN,
PolyPhen-2, PANTHER, MutPred 2 and I-Mutant 3.0. Table 2 sum-
marizes the results obtained for each amino acid substitution analyzed
individually. We also used Project HOPE to have an insight of each
amino acid substitution and of the possible effect on protein structure
and function. It is important to remark that these are all analysis of
single-site mutations comparing the stability of a theoretically one
mutated amino acid protein with the consensus.
To improve the strength of our analysis, data were evaluated by
combining all the tools used. Briefly, SIFT and PROVEAN categorized
the variants equivalently. The six variants detected by SIFT as dama-
ging or potentially damaging (C15W, C48G, Q65H, L70Q, V33F and
D60N) were also detected as deleterious by PROVEAN; the rest were
neutral with both tools. PolyPhen-2 and PANTHER also detected four
and three variants, respectively, of those six previously detected.
PolyPhen-2 detected a new probably damaging substitution (A68T),
while PANTHER classified two new substitutions as possibly damaging
(V33F and L44F). In addition, we performed I-Mutant 3.0 analysis of
GSTP1 in order to add another layer of refinement to the amino acid
substitution characterization, by considering the DDG change between
the native and mutated protein. This analysis yielded a significant de-
crease of almost all of the substitutions and the highest change (−2.58
Kcal/mol) for L70Q.
In each algorithm, distinct parameters were used to evaluate the
amino acid substitutions; the higher the number of significant results
for the substitution, the more likely they genuinely affected the struc-
ture and function of the protein. Thereby, whereas some substitutions
did not apparently affect (P3S, P43Q, L44F) or had a low influence
(V33F, V34L) on GSTP1 structure and stability, others exerted a
stronger influence (C15W, C48G, D60N, Q65H, A68T, L70Q).
3.3. Assessment of the effects of mutations on tertiary protein structure and
function
In order to further the study of these amino acid substitutions and
analyze their individual impact on protein structure and function, we
performed subsequent HOPE analysis. The results showed that in most
comparisons, the wild-type and mutant residues differed in their
properties.
All the possible substitutions occurred in the GSTP1 N-terminal
domain, where the binding site for GSH is located; from those sub-
stitutions, eight were also in contact with another domain of the protein
(P3S, V33F, V34L, P43Q, L44F, C48G, D60N, L70Q). Hence their sub-
stitution may modify the interactions between those two domains. To
summarize, most of the amino acids were substituted with larger re-
sidues (with the exception of P3S and C48G), leading to possible steric
problems and differences in protein folding. Furthermore, some re-
sidues were substituted with less hydrophobic amino acids (P3S, P43Q,
C48G, A68T, L70Q), which would generate a possible loss of hydro-
phobic interactions. On the other hand, since some residues were lo-
cated near (C15W and L44F) or directly involved (Q65H) in GSH
binding, their substitution could disturb the local structure and there-
fore protein activity. Finally, primary structure analysis of homologous
proteins showed that many of these positions were not conserved, some
of the new residues had similar properties to the homologous protein
alternative residues (V34L, P43Q, L70Q), and some had different
properties (P3S, V33F, C48G). In two cases, the mutant residue ap-
peared as a possible alternative amino acid (L44F and D60N), making a
substitution more likely to occur.
3.4. Protein structure homology modeling and analysis
So far, all substitutions were analyzed individually. Therefore, in
order to compare the accumulated effect of the different mutations, the
observed DNA sequencing predicted haplotypes were considered. As
Table 1
Amino acid substitutions predicted with DNA resequencing analysis.
p-Prot N° of p-mRNA 3 15 33 34 43 44 48 60 65 68 70
Consensus sequencea P C V V P L C D Q A L
I 4 – – – – – – – – – – –
II 1 – – – – – – – – – – Q
III 1 – – – L Q F G – – – –
IV 1 – – F – – – – – – – –
V 1 – W – – – – – – – – –
VI 2 – – – – – – – – – T –
VII 1 S – – – – F – N H – Q
p-Prot: predicted protein; p-mRNA: predicted mRNA.
a Consensus protein sequence from the NCBI database NP_803482.1.
Table 2
In silico analysis of the individual alternative amino acid substitutions detected in the resequencing stage, using different web-based tools.
Aminoacid position 3 15 33 34 43 44 48 60 65 68 70
NCBI Reference NP_803482.1 P C V V P L C D Q A L
Alternative amino acid S W F L Q F G N H T Q
Web-based tools SIFTa 0.3 0.02* 0.1* 0.12 0.5 0.23 0.05* 0.06 0* 0.34 0*
PROVEANb −2.135 −5.652* −3.459* −2.043 0.162 −1.498 −7.753* −3.634* −4.704* −2.102 −5.315*
PolyPhen-2c 0.006 1* 0.097 0.001 0.018 0.017 0.279* 0.021 1* 0.979* 1*
PANTHERd (millions of years) 176 176 361 750* 86 361 750* 750* 750* 1629* 750*
MutPred 2e 0.483 0.898* 0.279 0.220 0.236 0.121 0.822* 0.441 0.897* 0.829* 0.928*
I-Mutant 3.0f(Kcal/mol) −1.18* −1.02* −1.01* −0.81* −0.95* −0.88* −1.21* −0.06 −1.15* −0.75* −2.58*
* Highlights the significant predictions from each web-based tool.
a p-value< 0.05: damaging; 0.05–0.10: potentially damaging;> 0.10: neutral.
b score< −2.5: deleterious;> −2.5: neutral.
c probability> 0.85: probably damaging; 0.15–0.85: possibly damaging;< 0.15: benign.
d preservation time> 450: probably damaging; 200–450: possibly damaging;< 200; probably benign.
e probability> 0.8: pathogenic;< 0.8: non-pathogenic.
f Unfolding Gibbs free energy change (DDG)< -0.5: large decrease of stability; −0.5–0.5: neutral; > 0.5: large increase of stability.
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previously described, seven different translated proteins were obtained
from the 11 different haplotypes due to synonymous mutations.
Unfortunately, no crystallized structure of bovine GSTP1 was pub-
lically available in the PDB at the moment of this analysis. Therefore, all
the 3D structures were modeled using the I-TASSER server to compare
the wild-type and mutant proteins. For wild-type GSTP1, the protein
sequence available in the NCBI database (NP_803482.1) was used,
whereas for the mutant proteins, the seven p-Prot translated from the
eleven p-mRNAs were used. Despite I-TASSER is configured to show
five alternative models with the best score, only one structure was
generated for all seven p-Prot, indicating how conserved the structure
of this protein family is. Furthermore, the alignment of the GSTP1
primary sequence from different species showed little residue varia-
tions, and the GSH binding amino acids were particularly highly con-
served (Supplementary Figure 2).
The structures modeled were further analyzed using the Swiss
PdbViewer software. The protein and active site areas and volumes
were determined, as well as the RMSD of the backbone atoms of each p-
Prot from those of the modeled consensus sequence (Table 3). Since
there is no bovine GSTP1 structure published to compare, the human
crystallized structure 5GSS_A was used instead. The 5GSS_A structure
has an 86% sequence identity with the bovine GSTP1, with an addi-
tional 11% if amino acid similarity is considered, meaning it is a very
similar protein. Briefly, little variation was found in total protein sur-
face and volume, whilst more notorious changes were detected in sur-
face and volume of the cavity containing the active site.
4. Discussion
As was set there is a need to differentiate the false positive results
and prioritize variants for the biochemical analysis [8]. Analysis of the
NCBI dbSNP database (https://www.ncbi.nlm.nih.gov/snp) showed
that genes coding these enzymes present a high number of polymorphic
positions, many of which occur in coding regions. Accordingly, in this
research a total of 128 SNPs were found in the bovine GSTP1 gene
(mutation rate, one SNP every 25.6 bp), which was higher than the
approximated rate of one SNP every 100 bp reported [27]. From those
variants, 36 were located within the coding regions (mutation rate, one
SNP every 30.2 bp), demanding a prioritization to adequate and opti-
mize resources when deciding further in vitro or in vivo studies. Ad-
ditionally, a high diversity of the DNA sequence was observed when
comparing the gene in different species, despite, a high degree of
conservation was observed in protein primary sequence
(Supplementary Figure 2) suggesting that the genetic variation should
not affect greatly the protein to persist.
Within all the genomic information, non-synonymous SNPs
(nsSNPs) are important factors contributing to the functional diversity
of the encoded proteins within and between populations. In this sense,
prediction of the functional consequences of genetic variations would
help understand the molecular mechanisms underlying the observed
phenotypic variability. Synonymous SNPs could lead to RNA molecules
with possible different translation rates, which would have an impact
on protein folding, yielding altered conformations and ultimately
varying total enzyme activity [28]. In this study, we analyzed the
protein predicted tertiary structure, without considering synonymous
mutations since they would not produce differences in the primary
structure of proteins. Likewise, SNPs located in the promoter/reg-
ulatory region and introns may also have an effect on the phenotype
due to differential expression levels and altered mRNA conformation
[29,30]. Thereby, performance of wet laboratory experiments to study
the biological significance of each SNP would be a highly laborious task
as the great number of SNPs and their combinations would lead to an
exponential number of expensive and time-consuming experiments.
Nowadays, bioinformatics tools can be used for prioritization through a
better understanding of the effects caused by those genomic variants
and the screening of potentially deleterious SNPs, before conducting
further investigations [31].
Firstly the effect of each nsSNP can be analyzed to detect which of
them would have an effect on the protein structure and function. For
that task, the genetic variants can be studied using sequence- and
structure-based algorithms, such as SIFT, PROVEAN, PolyPhen-2,
PANTHER, MutPred 2 and I-Mutant 3.0. This analysis provides in-
formation from evolutionary and energetic points of view, analyzing
the conservation of residues in comparison to multiple alignments.
From the functional analysis, concordant results of all the tools in-
dicated that C15W, C48G, Q65H and L70Q may have an impact on
protein structure or function. Structure-based prediction using I-Mutant
3.0 also showed that almost all possible amino acid substitutions were
highly destabilizing (only D60N resulted in a neutral change in protein
stability), in agreement with the high degree of sequence conservation
of this protein among different species. Results of in silico analysis using
HOPE were in agreement as well. As this enzyme acts non-en-
zymatically in the apoptotic pathways [13] any structural variation
could lead to changes in the regulation of these processes. Additionally,
since all substitutions were located in the N-terminal domain
(Supplementary Figure 3), they would be important for the binding of
other molecules and the activity of GSTP1, especially glutamine in
Q65H, which is directly involved in GSH binding. It is worth noting
that, besides binding GSH, the residues around the pocket containing
the active site define the specificity for the second substrate. This
suggests that changes in molecular interactions and misfolding can af-
fect protein structure and function, and that these variants might be
functionally involved in differential oxidative stability and apoptosis
development.
A second step in this methodology is studying the haplotypes, in
order to evaluate the combined effect of the variants. In this sense, the
modeling of the tertiary structure of proteins allows to further under-
stand the effect of the possible amino acid substitutions. To begin with,
the consensus sequence of the protein was observed in all the breeds
studied (Table 1). Furthermore, its predicted structure showed an active
site volume and surface slightly deviated from the human crystallized
protein. Regarding the rest of p-Prot, four presented only one amino
acid substitution (II, IV, V and VI), while p-Prot III and VII presented
multiple amino acid substitutions. The substitution IV (V33F), where
valine was substituted by a bigger but still hydrophobic phenylalanine,
it may not result in a relevant change as this residue was protruding
outwards on the surface of the structure. While p-Prot II and V struc-
tures presented substitutions located inside the modeled structures,
these may influence protein folding, damaging protein structure and
function. In p-Prot V (C15W), the small hydrophilic cysteine is sub-
stituted by a big, hydrophobic tryptophan that may generate steric
problems, evidenced in the reduction in surface and volume of the
active site. On the other hand for p-Prot II (L70Q) the appearance of a
polar glutamine may generate a disruption of the interaction within the
core. On the contrary, the analysis of the modeled structure of p-Prot VI
Table 3
Surface and volume of the modeled proteins and active site, and Root mean
square deviation (RMSD) of the models against the consensus.
p-Prot Protein Active site Backbone RMSD
Surface Volume Surface Volume
I 9493 25,525 743 741 –
II 9142 25,782 818 762 0.378
III 9365 25,802 884 1102 0.473
IV 9331 25,673 745 757 0.411
V 9211 25,769 701 650 0.448
VI 9467 25,751 469 464 0.486
VII 8975 26,004 666 633 0.419
5GSS_A 8969 25,119 858 794 0.595
Backbone RMSD is the average difference in the position of the protein
backbone atoms compared with the consensus. Consensus (p-Prot I).
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showed that it had the greatest deviation from the consensus according
to RMSD results due to a reduction in the active site volume and surface
by almost a half. The A68T substitution produced a change in amino
acid properties, as the nonpolar alanine was replaced by a threonine
capable of generating new hydrogen bonds in the surroundings of the
active site (Supplementary Figure 4).
In the case of p-Prot III and VII, they presented multiple amino acid
substitutions, which reflected in the structure results. In p-Prot III, the
increased volume of the active site may be explained by the substitution
of the rigid proline in P43Q and the introduction of the flexible glycine
in C48G, in an α-helix near the active site (Supplementary Figure 5a).
This structure is located in an important loop that connects the two
typical structural motifs of a thioredoxin-like fold that constitutes the
structure of GSTs N-terminal domain [32]. Even though not predicted
as damaging, the rest of the substitutions in this structure were also
located in this loop (Supplementary Figure 5b), possibly contributing to
the observed differences in active site surface and volume. On the other
hand, p-Prot VII included probably the most important substitution,
Q65H, affecting a residue directly involved in GSH binding. Further-
more, the surface and volume of the active site were greatly reduced,
making this an interesting variant to be studied in vitro, since a change
in substrate binding, and therefore in enzymatic activity, would be
expected.
In summary, the presented methodology allowed to determine that
some of the predicted amino acid substitutions may generate important
changes in protein structure and function, and are good candidates to
be further studied in in vitro or in vivo experiments. These changes could
affect either the enzymatic activity, by altering the affinity for the
substrates, the reaction speed or the release of the products, or the non-
enzymatic function, trough a protein-protein interaction variation.
Moreover, the haplotype analysis enhanced this computational ap-
proach highlighting that the predicted structures III, VI and VII pre-
sented the greatest deviations in the protein structure or the active site
volume and surface, thus becoming prioritized structures for further
studies.
5. Conclusions
The present study aimed to demonstrate the advantages of a com-
putational methodology to systematically analyze the structural and
functional effects of protein variants, in order to prioritize further stu-
dies. This approach stands out for its easy implementation, low costs
and low time consumed. First, the possible impact of mutations on
protein structure and function was tested by a combination of tools
based on evolutionary and structural information. Next, homology
modeling was performed to predict and compare the 3D protein
structures of unresolved amino acid sequences obtained from genomic
resequencing. This analysis applied to the bovine GSTP1 highlighted
three structure variants worthwhile studying in vitro.
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